Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · IEX Real-Time Price · USD

55.78

-2.50 (-4.29%)

At close: Apr 22, 2024, 4:00 PM

58.56

+2.78 (4.98%)

After-hours: Apr 22, 2024, 7:44 PM EDT

Keros Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-152.99	-104.68	-58.74	-45.36	-14.14	-2.35
Depreciation & Amortization	2.37	1.62	0.9	0.61	0.44	0.3
Share-Based Compensation	28.76	18.68	11.72	4.1	0.06	0.08
Other Operating Activities	-2.65	14.32	-16.02	3.77	-2.36	9
Operating Cash Flow	-124.51	-70.06	-62.15	-36.89	-16	7.04
Capital Expenditures	-2.46	-1.24	-1.02	-0.29	-0.27	-0.22
Investing Cash Flow	-2.46	-1.24	-1.02	-0.29	-0.27	-0.22
Share Issuance / Repurchase	179.05	120.4	28.55	240.69	0.01	0.01
Other Financing Activities	-0.09	-0.09	-	55.35	-	11.46
Financing Cash Flow	178.96	120.31	28.55	296.04	0.01	11.46
Net Cash Flow	51.98	49.01	-34.62	258.86	-16.26	18.29
Free Cash Flow	-126.97	-71.3	-63.17	-37.19	-16.27	6.83
Free Cash Flow Margin	-84087.42%	-	-314.29%	-	-162.69%	68.25%
Free Cash Flow Per Share	-4.31	-2.83	-2.71	-2.40	-6.99	3.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).